Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

1998 • 6,250 citations

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

1999 • 3,464 citations

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1998 • 2,421 citations

Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies

1996 • 2,037 citations

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

1996 • 1,658 citations

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

1999 • 1,549 citations

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

1992 • 1,341 citations

The mortality of rheumatoid arthritis

1994 • 1,323 citations

Effect of Pravastatin on Outcomes after Cardiac Transplantation

1995 • 1,302 citations

Drug Treatment of Lipid Disorders

1999 • 863 citations

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

1992 • 784 citations

Visceral abdominal-fat accumulation associated with use of indinavir

1998 • 717 citations

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

1992 • 625 citations

Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

1999 • 615 citations

A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease

1995 • 569 citations

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients

1998 • 542 citations

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors

1999 • 533 citations

Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

2000 • 499 citations

National cholesterol education program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)

1994 • 469 citations

Cholesterol Reduction Yields Clinical Benefit

1998 • 462 citations

Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation

1997 • 449 citations

Angiographic Assessment of Effects of Bezafibrate on Progression of Coronary Artery Disease in Young Male Postinfarction Patients

1996 • 415 citations

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole*

1998 • 402 citations

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

2000 • 398 citations

Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol

1997 • 394 citations

Comparison of Statins in Hypertriglyceridemia

1998 • 387 citations

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1992 • 341 citations

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine

1999 • 336 citations

Outcome in Systemic Lupus Erythematosus

1989 • 320 citations

Effect of itraconazole on the pharmacokinetics of atorvastatin*

1998 • 295 citations

Adverse Metabolic Effect of Omega-3 Fatty Acids in Non-Insulin-Dependent Diabetes Mellitus

1988 • 289 citations

Cholesterol Reduction Yields Clinical Benefit

1995 • 283 citations

Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

1991 • 282 citations

Nicotinic Acid as Therapy for Dyslipidemia in Non—Insulin-Dependent Diabetes Mellitus

1990 • 278 citations

Effects of Cyclosporine Therapy on Plasma Lipoprotein Levels

1989 • 270 citations

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1996 • 241 citations

Increased de novo hepatic lipogenesis in human immunodeficiency virus infection.

1993 • 225 citations

Metabolism and Drug Interactions of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Transplant Patients

1998 • 223 citations

Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection

1993 • 201 citations

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine

1998 • 189 citations

The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.

1993 • 187 citations

Mechanism of action of gemfibrozil on lipoprotein metabolism.

1985 • 186 citations

Increased β-Cell Secretory Capacity as Mechanism for Islet Adaptation to Nicotinic Acid-Induced Insulin Resistance

1989 • 181 citations

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

1996 • 178 citations

Vascular complications associated with use of HIV protease inhibitors

1998 • 168 citations

Long-Term Effects of Fish Oil on Insulin Resistance and Plasma Lipoproteins in NIDDM Patients With Hypertriglyceridemia

1996 • 167 citations

Micronised Fenofibrate

1997 • 139 citations

Biological Effects of ω-3 Fatty Acids in Diabetes Mellitus

1991 • 135 citations

Marked hyperlipidaemia on ritonavir therapy.

1997 • 111 citations

Increased de novo hepatic lipogenesis in human immunodeficiency virus infection

1993 • 110 citations

Vascular complications associated with use of HIV protease inhibitors

1998 • 108 citations

Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex

1992 • 104 citations

Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine Production

1996 • 77 citations

The Role of the Cytokines, Interferon Alpha and Tumor Necrosis Factor in the Hypertriglyceridemia and Wasting of AIDS ,

1992 • 73 citations

Rational Assessment of the Interaction Profile of Cerivastatin Supports its Low Propensity for Drug Interactions

1998 • 66 citations

The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B

1993 • 57 citations

Hepatic Microsomal Enzyme Induction, β-Oxidation, and Cell Proliferation Following Administration of Clofibrate, Gemfibrozil, or Bezafibrate in the CD Rat

1997 • 46 citations

Alterations in Serum Levels of Lipids and Lipoproteins with Indinavir Therapy for Human Immunodeficiency Virus‐Infected Patients

1999 • 44 citations

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance

1989 • 36 citations

Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels

1998 • 33 citations

EFFICACY AND MUSCLE SAFETY OF FLUVASTATIN IN CYCLOSPORINE-TREATED CARDIAC AND RENAL TRANSPLANT RECIPIENTS

1998 • 25 citations

Abstracts

1999 • 3 citations